VLA1601
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VLA1601, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults [Phase 1]